Skip to main content

Table 1 Baseline characteristics of the patients included in the study

From: An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline

Male

25 (58%)

Age (years)

35 ± 13

Age > 65 years

0

Hypertension

0

Smoke

18 (42%)

Dyslipidemia

4 (9%)

Family history of heart disease

8 (19%)

Chronic kidney disease

0

Mediastinal RT (non-cardiac field)

6 (14%)

Doxorubicin dose (mg/m2)

251 ± 57

ECHOPRE

26 (60%)

LVEDD (mm)

47.2 ± 5.2

LVESD (mm)

28.2 ± 3.9

LVEF (%)

70.3 ± 7.1

  1. RT: radiotherapy; ECHOPRE: baseline echocardiography; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVEF: left ventricular ejection fraction